With these points in mind, the purpose of this ECDP is to provide practical and timely guidance on the diagnosis and management of cardiac amyloidosis with an emphasis on the pitfalls in diagnosis and the role of multidisciplinary collaboration in optimizing management.
This guideline provides evidence-based recommendations for the management of cardiac arrest and the arrhythmias associated with ACS, chronic CHD and cardiac surgery. It excludes arrhythmias not associated with CHD such as...
Although infusion of fibrinogen concentrate is increasingly used in bleeding patients after cardiac surgery, safety data are scarce. We aimed to evaluate the effect of perioperative administration of fibrinogen...
This guideline provides evidence-based recommendations and best practice guidance on the management of patients referred for cardiac rehabilitation.
To evaluate the effect of Plasma-Lyte 148 (PL-148) compared with 0.9% saline (saline) on blood product use and postoperative bleeding in patients admitted to the intensive care unit (ICU) following cardiac surgery.
Objectives:To determine the clinical benefit of using colloids versus crystalloids for volume resuscitation in children admitted after cardiac surgery.
Fibrinogen concentrate increasingly is used to treat coagulopathic bleeding in cardiac surgery although its effectiveness and safety have not been shown. The authors conducted a cohort study to quantify the effects of...
Abbott announced CE Mark and first use of the new Confirm Rx Insertable Cardiac Monitor (ICM), the world's first smartphone...
Patients undergoing cardiac surgery with and potentially without cardiopulmonary bypass (CPB) are at risk for excessive microvascular bleeding. This bleeding often leads to transfusion of allogeneic blood and blood components as...
Royal Philips announced the launch of the HeartStart Intrepid monitor/defibrillator with IntelliSpace Connect. Created to provide clinical and operational efficiencies...